FDA gives Pfizer-BioNTech covid-19 vaccine full approval
- Clearance of the shot, for people 16 years and older, is the agency’s first full approval of a Covid-19 vaccine
The Covid-19 vaccine from Pfizer Inc. and partner BioNTech SE received full approval from U.S. regulators Monday, which many public health officials and vaccine experts hope will encourage hesitant populations to get the shot.
Select your Category
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more